SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 504.95 |
Enterprise Value ($M) | 455.36 |
Book Value ($M) | -17.15 |
Book Value / Share | -0.15 |
Price / Book | -29.45 |
NCAV ($M) | -17.59 |
NCAV / Share | -0.15 |
Price / NCAV | -28.70 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -3.99 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.76 |
Current Ratio | 0.76 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 54.39 |
Assets | 54.83 |
Liabilities | 71.98 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 9.99 |
Operating Income | -64.53 |
Net Income | -119.76 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -55.17 |
Cash from Investing | 13.87 |
Cash from Financing | 74.54 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Janus Henderson Group Plc | 6.10 | ||
13D/A | Shendelman Shoshana | 8.20 | 7.00 | |
13G/A | Propel Bio Management, LLC | 10.50 | 69.66 | |
13G/A | Alyeska Investment Group, L.P. | 9.99 | 60.57 | |
13G/A | Venrock Healthcare Capital Partners III, L.P. | 9.99 | 35.88 | |
13G/A | Orbimed Advisors Llc | 0.00 | -100.00 | |
13G/A | Armistice Capital, Llc | 0.00 | -100.00 | |
13G/A | Alexandria Real Estate Equities, Inc. | 15.40 | -4.28 | |
13G/A | Perceptive Advisors Llc | 5.90 | 0.00 | |
13G | Vestal Point Capital, LP | 5.40 | ||
13G/A | Fmr Llc | 3.14 | -18.33 | |
13G/A | Franklin Resources Inc | 9.99 | -0.98 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
101,440 | 495,470 | 20.47 | |
92,616 | 131,227 | 70.58 | |
37,567 | 153,203 | 24.52 | |
50,185 | 210,927 | 23.79 | |
(click for more detail) |
Similar Companies | |
---|---|
ALT – Altimmune, Inc. | ANIP – ANI Pharmaceuticals, Inc. |
APGE – Apogee Therapeutics, Inc. | AQST – Aquestive Therapeutics, Inc. |
ARCT – Arcturus Therapeutics Holdings Inc. |
Financial data and stock pages provided by
Fintel.io